Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Novartis ag save search
Dr. Reddy's Laboratories announces the launch of Difluprednate Ophthalmic Emulsion 0.05% in the U.S. Market
Published: 2023-01-27 (Crawled : 13:00) - biospace.com/
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: 0.0%
market
Lipid Based Formulations Global Market Report 2023: Featuring Novartis, AbbVie, F. Hoffmann-La Roche, Johnson & Johnson, Alnylam Pharmaceuticals & More
Published: 2023-01-27 (Crawled : 12:20) - prnewswire.com
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: 0.0%
JNJ | News 3 d | $168.23 -0.39% -0.04% 6M
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
pharmaceuticals global report market
Global Infertility Drugs Market Report 2022: Sector to Reach $4.8 Billion by 2028 at a 6.2% CAGR
Published: 2023-01-26 (Crawled : 00:00) - prnewswire.com
PFE | $43.79 -1.04% 0.0% 23M
|
Health Technology
|
| O: -0.05%
H: 0.0%
C: 0.0%
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: 0.0%
ABT | News | $109.95 -1.01% 0.0% 4.9M
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: 0.0%
SNY | News | $48.49 -0.66% -0.66% 1.1M
|
Health Technology
|
| O: -1.25%
H: 0.0%
C: 0.0%
global report market
Intravitreal Injectables Global Market Report 2022: Featuring Allergan, Bristol-Myers Squibb, Novartis, F.Hoffman-La Roche & More
Published: 2023-01-26 (Crawled : 18:00) - prnewswire.com
NVSEF | News 4 d | $90.0 0
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M
|
Health Technology
|
| O: -1.25%
H: 0.0%
C: 0.0%
BMY | News | $72.45 -0.74% 0.0% 5.4M
|
Health Technology
|
| O: 0.7%
H: 0.0%
C: 0.0%
REGN | News | $742.84 0.07% 0.07% 410K
|
Health Technology
|
| O: 1.46%
H: 0.0%
C: 0.0%
global report roche market
Worldwide Orthopedic Oncology Treatment Industry to 2030 - Dominating Segment is Reconstructive Surgery
Published: 2023-01-26 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $97.85 0
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
NVSEF | News 4 d | $90.0 0
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
ZBH | News | $125.88 0.3% 0.0% 1.4M
|
Health Technology
|
| O: 1.12%
H: 0.0%
C: 0.0%
SYK | News | $254.17 0.7% 0.0% 1M
|
Health Technology
|
| O: 0.78%
H: 0.0%
C: 0.0%
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M
|
Health Technology
|
| O: -1.25%
H: 0.0%
C: 0.0%
JNJ | News 3 d | $168.23 -0.39% -0.04% 6M
|
Health Technology
|
| O: 1.29%
H: 0.0%
C: 0.0%
SNY | News | $48.49 -0.66% -0.66% 1.1M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
treatment
Global Psoriasis Therapeutics Market Report to 2031 - Featuring Abbvie, Amgen, Bausch Health, LEO Pharma and Novan Among Others
Published: 2023-01-25 (Crawled : 21:00) - prnewswire.com
NVSEF | News 4 d | $90.0 0
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
VTRS | $11.89 2.15% 2.1% 9.9M
|
Health Technology
|
| O: 0.0%
H: 0.87%
C: 0.69%
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M
|
Health Technology
|
| O: -1.25%
H: 0.0%
C: 0.0%
LLY | News | $342.1 -1.7% 0.12% 2.3M
|
Health Technology
|
| O: 1.48%
H: 0.34%
C: -0.85%
BHC | $8.38 -1.64% 0.0% 4.7M
|
Health Technology
|
| O: 2.77%
H: 3.28%
C: -0.23%
ABBV | News | $146.28 -0.76% 0.06% 4.6M
|
Health Technology
|
| O: 0.15%
H: 0.0%
C: 0.0%
AMGN | News | $253.68 -0.47% -0.47% 2.1M
|
Health Technology
|
| O: -1.76%
H: 0.0%
C: 0.0%
leo pharma global report therapeutics psoriasis market
Insights on the Alzheimer's Drugs Global Market to 2027 - Hospital Sector will Capture more Revenue in Upcoming Years
Published: 2023-01-25 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $97.85 0
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
NVSEF | News 4 d | $90.0 0
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
PFE | $43.79 -1.04% 0.0% 23M
|
Health Technology
|
| O: -1.87%
H: 0.0%
C: 0.0%
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M
|
Health Technology
|
| O: -1.25%
H: 0.0%
C: 0.0%
GSK | News | $35.3 -0.11% 0.14% 3.5M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
LLY | News | $342.1 -1.7% 0.12% 2.3M
|
Health Technology
|
| O: 1.48%
H: 0.34%
C: -0.85%
ABT | News | $109.95 -1.01% 0.0% 4.9M
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
SNY | News | $48.49 -0.66% -0.66% 1.1M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
global alzheimer's market
Ophthalmology therapeutics market size to increase by USD 15.72 billion: North America will account for 44% of market growth - Technavio
Published: 2023-01-24 (Crawled : 19:00) - prnewswire.com
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M
|
Health Technology
|
| O: 0.17%
H: 0.0%
C: 0.0%
ABBV | News | $146.28 -0.76% 0.06% 4.6M
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: 0.0%
america for therapeutics growth market
Sandoz announces agreement to acquire leading antifungal agent Mycamine® from Astellas, reinforcing hospital offering and leading Anti-Infectives portfolio
Published: 2023-01-23 (Crawled : 00:00) - globenewswire.com
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M
|
Health Technology
|
| O: -0.14%
H: 0.48%
C: 0.36%
mycamine offering acquire antifungal agreement
Allergy immunotherapies market: Driving factors, industry challenges, segmentation, key vendor analysis, leading countries, and market size and forecast 2023-2027 - Technavio
Published: 2023-01-23 (Crawled : 19:00) - prnewswire.com
VTRS | $11.89 2.15% 2.1% 9.9M
|
Health Technology
|
| O: -0.51%
H: 0.26%
C: -1.36%
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M
|
Health Technology
|
| O: -0.14%
H: 0.48%
C: 0.36%
market
Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
Published: 2023-01-23 (Crawled : 17:00) - biospace.com/
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
Addiction Disorders Drugs Market Report 2022: Sector to Reach $32.65 Billion by 2027 at a CAGR of 6.35%
Published: 2023-01-21 (Crawled : 16:20) - prnewswire.com
GLAXF | News | $17.3 0
|
Health Technology
| Email alert
Add to watchlist
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M
|
Health Technology
| Email alert
Add to watchlist
PMD | $5.53 1.63% 1.1K
|
Health Services
| Email alert
Add to watchlist
NVSEF | News 4 d | $90.0 0
|
Health Technology
| Email alert
Add to watchlist
PRGO | $37.2 1.53% 0.0% 680K
|
Health Technology
| Email alert
Add to watchlist
ALKS | $29.04 1.9% 1.86% 1.2M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $35.3 -0.11% 0.14% 3.5M
|
Health Technology
| Email alert
Add to watchlist
MDT | News | $82.58 0.9% 0.47% 4.8M
|
Health Technology
| Email alert
Add to watchlist
report market
Global Transdermal Drug Delivery Market to Reach $131.2 Billion by 2027
Published: 2023-01-21 (Crawled : 16:20) - prnewswire.com
DRRX | $6.62 1.69% 1.66% 35K
|
Health Technology
| Email alert
Add to watchlist
TEVJF | $9.61 0
|
Health Technology
| Email alert
Add to watchlist
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News 4 d | $90.0 0
|
Health Technology
| Email alert
Add to watchlist
ATRS | $5.59 0.0%
|
Health Technology
| Email alert
Add to watchlist
drug global transdermal market
The Worldwide Animal Biotechnology Industry is Expected to Reach $48.9 Billion by 2030
Published: 2023-01-20 (Crawled : 22:00) - prnewswire.com
HSKA | $87.11 -0.63% -0.63% 66K
|
Health Technology
| Email alert
Add to watchlist
ZTS | $165.18 -1.82% -0.23% 1.8M
|
Health Technology
| Email alert
Add to watchlist
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News 4 d | $90.0 0
|
Health Technology
| Email alert
Add to watchlist
expected animal
Global Prescription Drugs Market Analysis Report 2022: Increasing Number of Chronic Diseases Worldwide will Continue to Fuel Growth - Forecast to 2027
Published: 2023-01-19 (Crawled : 17:00) - prnewswire.com
TAK | News | $16.03 -0.43% 0.0% 3.7M
|
Health Technology
|
| O: 0.03%
H: 0.0%
C: 0.0%
NVO | $138.09 0.4% 1.38% 1.1M
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: 0.0%
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
JNJ | News 3 d | $168.23 -0.39% -0.04% 6M
|
Health Technology
|
| O: -1.45%
H: 0.0%
C: 0.0%
GSK | News | $35.3 -0.11% 0.14% 3.5M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
LLY | News | $342.1 -1.7% 0.12% 2.3M
|
Health Technology
|
| O: -1.35%
H: 0.0%
C: 0.0%
BMY | News | $72.45 -0.74% 0.0% 5.4M
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: 0.0%
ABBV | News | $146.28 -0.76% 0.06% 4.6M
|
Health Technology
|
| O: -2.16%
H: 0.0%
C: 0.0%
SNY | News | $48.49 -0.66% -0.66% 1.1M
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
GILD F | $83.7 0.1% 0.1% 4.1M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
AMGN | News | $253.68 -0.47% -0.47% 2.1M
|
Health Technology
|
| O: -0.9%
H: 0.0%
C: 0.0%
global report growth market
Pharmascience Canada launched (PR)pms-DEFERASIROX (TYPE J), a generic drug indicated in the management of chronic iron
Published: 2023-01-18 (Crawled : 19:00) - biospace.com/
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M
|
Health Technology
|
| O: 0.08%
H: 0.01%
C: -1.16%
management drug canada
Dermatology Drugs Market to Experience Substantial Growth of USD 37.33 Million by 2029, Size, Share, Growth Rate, Market Demand, Opportunities and Competitive Landscape: Report by Data Bridge Market Research
Published: 2023-01-18 (Crawled : 19:00) - prnewswire.com
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
JNJ | News 3 d | $168.23 -0.39% -0.04% 6M
|
Health Technology
|
| O: -1.45%
H: 0.0%
C: 0.0%
BMY | News | $72.45 -0.74% 0.0% 5.4M
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: 0.0%
SNY | News | $48.49 -0.66% -0.66% 1.1M
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
AMGN | News | $253.68 -0.47% -0.47% 2.1M
|
Health Technology
|
| O: -0.9%
H: 0.0%
C: 0.0%
research report growth market
Worldwide Monoclonal Antibodies Industry to 2033 - Rising mAb Therapy Applications for Targeted Therapies Drives Growth
Published: 2023-01-18 (Crawled : 18:00) - prnewswire.com
VTRS | $11.89 2.15% 2.1% 9.9M
|
Health Technology
|
| O: -0.17%
H: 0.25%
C: -2.96%
TMO | News | $573.63 -0.65% -0.03% 1.1M
|
Health Technology
|
| O: 0.56%
H: 0.97%
C: -1.87%
NVO | $138.09 0.4% 1.38% 1.1M
|
Health Technology
|
| O: 0.57%
H: 0.84%
C: -0.01%
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M
|
Health Technology
|
| O: 0.08%
H: 0.01%
C: -1.16%
JNJ | News 3 d | $168.23 -0.39% -0.04% 6M
|
Health Technology
|
| O: -1.47%
H: 0.0%
C: 0.0%
GSK | News | $35.3 -0.11% 0.14% 3.5M
|
Health Technology
|
| O: -0.03%
H: 0.17%
C: -1.01%
LLY | News | $342.1 -1.7% 0.12% 2.3M
|
Health Technology
|
| O: -1.13%
H: 0.0%
C: 0.0%
ABT | News | $109.95 -1.01% 0.0% 4.9M
|
Health Technology
|
| O: -0.16%
H: 0.33%
C: -1.5%
SNY | News | $48.49 -0.66% -0.66% 1.1M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
BIIB A | $290.0 -0.66% -0.66% 890K
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
AZN | $65.54 -0.68% -0.69% 3.1M
|
Health Technology
|
| O: 1.36%
H: 0.33%
C: -1.13%
AMGN | News | $253.68 -0.47% -0.47% 2.1M
|
Health Technology
|
| O: 0.0%
H: 0.41%
C: -1.87%
for therapy growth
LAMEA Attention Deficit Hyperactivity Disorder Market 2022: Sector to Grow by 7.3% Annually Through 2028
Published: 2023-01-18 (Crawled : 12:00) - prnewswire.com
MNK | $7.6 -1.81% 0.0% 18K
|
n/a
|
| O: 0.95%
H: 3.25%
C: -3.0%
TAK | News | $16.03 -0.43% 0.0% 3.7M
|
Health Technology
|
| O: 0.87%
H: 0.12%
C: -0.68%
PFE | $43.79 -1.04% 0.0% 23M
|
Health Technology
|
| O: -1.99%
H: 0.67%
C: -1.2%
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M
|
Health Technology
|
| O: 0.08%
H: 0.01%
C: -1.16%
JNJ | News 3 d | $168.23 -0.39% -0.04% 6M
|
Health Technology
|
| O: -1.47%
H: 0.0%
C: 0.0%
LLY | News | $342.1 -1.7% 0.12% 2.3M
|
Health Technology
|
| O: -1.13%
H: 0.0%
C: 0.0%
SUPN | $40.68 -0.93% -0.93% 350K
|
Health Technology
|
| O: 0.4%
H: 2.69%
C: 0.32%
market
Multiple Sclerosis Patients in US Left Without Essential Patient Support Program Will Now Receive Equivalent Backing From Cycle Pharmaceuticals Following FDA’s Approval of TASCENSO ODT® (fingolimod)
Published: 2023-01-17 (Crawled : 19:00) - biospace.com/
NVS | News 4 d | $89.49 -0.39% 0.01% 1.7M
|
Health Technology
|
| O: 2.62%
H: 0.0%
C: 0.0%
odt pharmaceuticals program approval sclerosis
Gainers vs Losers
| 66% | 34% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.